← All organizations

Yichang Humanwell Pharmaceutical Co.,Ltd

For profit

Also known as: HUMANWELL PHARMACEUTICAL US INC | HUMANWELL PURACAP | Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | WUHAN HUMANWELL LIKANG PHARMACEUTICAL CO. LTD. | YICHANG HUMANWELL | Yichang Humanwell Pharmaceutical Co.,Ltd | Yichang Humanwell Pharmaceutical Co., Ltd., China

Highest phase reached

Phase 4

First clinical trial

Dec 1, 2015

First marketed drug

Jun 21, 2016

Last known activity

May 4, 2026

Timeline

1950s

  1. Jun 1, 1954

    Yichang Humanwell Pharmaceutical Co.,Ltd— Founded

2010s

  1. Oct 2, 2017

    Ritedose— Acquired

2020s

  1. Apr 2, 2021

    memantine— Marketing Organization

Drugs by trial phase (11 distinct, 9 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (24)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (9)

Details

Founded
Hubei, CN Jun 1, 1954
Last known activity
May 4, 2026